Exploring the Impact of Dynamic Defocus Display Schemes on Ocular Health Indicators
Key facts
- Who runs it
- Beijing Tongren Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 36 people enrolled
- Started
- 20 Aug 2025
- Ended
- 30 Nov 2025
- Type of study
- Interventional, 5 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Dynamic Defocus Mode
- Record updated
- 18 December 2025
Who can take part
- Age
- 20 years to 40 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Adults aged between 20 and 40 years, regardless of gender
- Refractive anisometropia ≤2.5D and corrected visual acuity of 1.0 or above in both eyes
- Habitual long-term use of electronic devices with LED light sources, such as computers and smartphones
- Currently not using any other blue light protection products or having ceased the use of such products for at least 2 weeks
- No known visually significant ophthalmic diseases
- Willing to participate in the trial and having signed the informed consent form
Who cannot take part
- Severe dry eye or history of ocular medication use
- Acute or chronic ocular surface inflammation, keratoconus, history of ocular surgery (e.g., refractive surgery), systemic diseases, or other conditions (e.g., wearing orthokeratology lenses and using atropine)
- Photosensitivity, history of epilepsy, etc
- Abnormal accommodative function or other visual function abnormalities (e.g., strabismus, amblyopia)
- Individuals unable to cooperate with the examination
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The present study is designed to explore the effects of dynamic defocus display technology on ocular health parameters using rigorous scientific approaches. It further examines the mechanisms through which this technology alleviates visual fatigue, thereby providing robust clinical evidence to support its practical application and widespread adoption.
The 5 groups in the trial
- Control groupNo study treatment, for comparison
This group serves as the baseline comparison. Participants will perform the video-watching task on a conventional display with no intervention, allowing for the assessment of typical visual fatigue and ocular health indicators under standard conditions.
- Intervention Group A (Low defocus amplitude and high frequency)Treatment being tested
Participants will use a display with Dynamic Defocus Mode with low defocus amplitude and high frequency to perform a video browsing task. This group is designed with a specific dynamic defocus adjustment scheme, aimed at investigating the extent to which different dynamic defocus schemes can improve visual fatigue. Participants will be single-blinded to their group assignment. The intervention involves Dynamic Defocus Mode 1 and follows the VDT task protocol as designed in the trial.
Treatment: Dynamic Defocus Mode
- Intervention Group B (low defocus amplitude and low frequency)Treatment being tested
Participants will use a display with Dynamic Defocus Mode with low defocus amplitude and low frequency to perform a video browsing task. This group is designed with a specific dynamic defocus adjustment scheme, aimed at investigating the extent to which different dynamic defocus schemes can improve visual fatigue. Participants will be single-blinded to their group assignment. The intervention involves Dynamic Defocus Mode 1 and follows the VDT task protocol as designed in the trial.
Treatment: Dynamic Defocus Mode
- Intervention Group C (high defocus amplitude and high frequency)Treatment being tested
Participants will use a display with Dynamic Defocus Mode with high defocus amplitude and high frequency to perform a video browsing task. This group is designed with a specific dynamic defocus adjustment scheme, aimed at investigating the extent to which different dynamic defocus schemes can improve visual fatigue. Participants will be single-blinded to their group assignment. The intervention involves Dynamic Defocus Mode 1 and follows the VDT task protocol as designed in the trial.
Treatment: Dynamic Defocus Mode
- Intervention Group D (high defocus amplitude and low frequency)Treatment being tested
Participants will use a display with Dynamic Defocus Mode with high defocus amplitude and low frequency to perform a video browsing task. This group is designed with a specific dynamic defocus adjustment scheme, aimed at investigating the extent to which different dynamic defocus schemes can improve visual fatigue. Participants will be single-blinded to their group assignment. The intervention involves Dynamic Defocus Mode 1 and follows the VDT task protocol as designed in the trial.
Treatment: Dynamic Defocus Mode
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 18 December 2025